Clinical Trials Browser

Phase 3 × OTHER × Pamidronate × Clear all

NCT00376883 2007-01-04

Pamidronate Prophylaxis in Multiple Myeloma 30 mg/Month Versus 90 mg/Month

Phase 3 Completed

Multiple Myeloma